换一批
换一批Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
作者：
Irene J,Beijert [1]
;
Anouk E,Hentschel [2]
;
Johannes,Bründl [1]
;
Eva M,Compérat [2]
;
Karin,Plass [3]
;
Oscar,Rodríguez [4]
;
Jose D,Subiela Henríquez [5]
;
Virginia,Hernández [6]
;
Enrique,de la Peña [7]
;
Isabel,Alemany [7]
;
Diana,Turturica [4]
;
Francesca,Pisano [8]
;
Francesco,Soria [8]
;
Otakar,Čapoun [9]
;
Lenka,Bauerová [10]
;
Michael,Pešl [7]
;
H Maxim,Bruins [10]
;
Willemien,Runneboom [10]
;
Sonja,Herdegen [4]
;
Johannes,Breyer [11]
;
Antonin,Brisuda [12]
;
Ana,Calatrava [11]
;
José,Rubio-Briones [4]
;
Maximilian,Seles [13]
;
Sebastian,Mannweiler [14]
;
Judith,Bosschieter [15]
;
Venkata R M,Kusuma [3]
;
David,Ashabere [3]
;
Nicolai,Huebner [16]
;
Juliette,Cotte [17]
;
Roberto,Contieri [18]
;
Laura S,Mertens [19]
;
Francesco,Claps [20]
;
Alexandra,Masson-Lecomte [2]
;
Fredrik,Liedberg [21]
;
Daniel,Cohen [21]
;
Luca,Lunelli [22]
;
Olivier,Cussenot [23]
;
Soha,El Sheikh [1]
;
Dimitrios,Volanis [1]
;
Jean-François,Côté [1]
;
Morgan,Rouprêt [4]
;
Andrea,Haitel [4]
;
Shahrokh F,Shariat [4]
;
A Hugh,Mostafid [24]
;
Jakko A,Nieuwenhuijzen [25]
;
Richard,Zigeuner [25]
;
Jose L,Dominguez-Escrig [26]
;
Jaromir,Hacek [24]
;
Alexandre R,Zlotta [27]
;
Maximilian,Burger [4]
;
Matthias,Evert [23]
;
Christina A,Hulsbergen-van de Kaa [28]
;
Antoine G,van der Heijden [4]
;
Lambertus A L M,Kiemeney [16]
;
Viktor,Soukup [22]
;
Luca,Molinaro [4]
;
Paolo,Gontero [21]
;
Carlos,Llorente [2]
;
Ferran,Algaba [4]
;
Joan,Palou [19]
;
James,N'Dow [4]
;
Maria J,Ribal [18]
;
Theo H,van der Kwast [29]
;
Marko,Babjuk [30]
;
Richard J,Sylvester [3]
;
Bas W G,van Rhijn [4]
作者单位：
Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
[1]
Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
[2]
Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
[3]
European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.
[4]
Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.
[5]
European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.
[6]
Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
[7]
Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
[8]
Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
[9]
Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.
[10]
Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
[11]
Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
[12]
Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
[13]
Urology, Zuyderland Medical Center, Sittard/Heerlen, The Netherlands.
[14]
Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
[15]
Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
[16]
Pathology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.
[17]
Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.
[18]
Urology, Medical University of Graz, Graz, Austria.
[19]
Pathology, Medical University of Graz, Graz, Austria.
[20]
Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.
[21]
Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.
[22]
Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France.
[23]
Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.
[24]
Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.
[25]
Pathology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.
[26]
Pathology, Pierre et Marie Curie Medical School, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.
[27]
Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.
[28]
Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
[29]
Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
[30]
Pathology, University of Regensburg, Regensburg, Germany.
[31]
Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
[32]
Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.
[33]
Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
[34]
Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
[35]
Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.v.rhijn@nki.nl.
[36]
Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany. b.v.rhijn@nki.nl.
[37]
European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. b.v.rhijn@nki.nl.
[38]
Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. b.v.rhijn@nki.nl.
[39]
主题词
人类(Humans);膀胱肿瘤(Urinary Bladder Neoplasms);预后(Prognosis);泌尿外科手术(Urologic Surgical Procedures);膀胱(Urinary Bladder);膀胱切除术(Cystectomy);肿瘤分期(Neoplasm Staging)
DOI
10.1007/s11255-023-03867-9
PMID
37980689
发布时间
2024-04-13
- 浏览1
International urology and nephrology
International urology and nephrology
1323-1333页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
